EQ Equillium, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 13, 2026
$1,41
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$0,76rendah 52m
$3,54tinggi 52m
Kapitalisasi Pasar (MRQ)
$89M
P/E
-3.6
EPS
$-0.39
Pendapatan
$41M
lencana Anda
Rentang 52M
$1–$4
Peringkat Analis
BUY
Target Harga
$9
P/E
-3.6
ROE
-133.1%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
EQ Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$1.41
Kapitalisasi Pasar (MRQ)
$89M
P/E
-3.6
EPS
$-0.39
Pendapatan
$41M
ROE
-133.1%
Rentang 52M
$1–$4
EQ Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$41M2022-12-31 → 2024-12-31
EPS$-0.392021-12-31 → 2025-12-31
Arus Kas Bebas$-23M2018-12-31 → 2025-12-31
Margin bersih·2022-12-31 → 2024-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | EQ | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -3.6rata-rata 5T ≈-2.5 | ≈-2.5 | · | · | |
| P/S | 1.9rata-rata 5T ≈1.4 | ≈1.4 | 16.0 | Kurang nilai | |
| P/B (MRQ) | 1.6rata-rata 5T ≈1.7 | ≈1.7 | 6.2 | Kurang nilai | |
| Harga / FCF (TTM) | -4.5rata-rata 5T ≈-2.8 | ≈-2.8 | · | · | |
| Harga / Arus Kas (TTM) | -4.5rata-rata 5T ≈-2.9 | ≈-2.9 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 3.0rata-rata 5T ≈1.7 | ≈1.7 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | EQ | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -77.9%rata-rata 5T ≈-48.3% | ≈-48.3% | -54.1% | Lemah | |
| ROE | -133.1%rata-rata 5T ≈-98.2% | ≈-98.2% | -95.9% | Lemah | |
| ROIC | -82.7%rata-rata 5T ≈-75.4% | ≈-75.4% | -87.8% | Sejajar |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | EQ | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 23.4rata-rata 5T ≈5.6 | ≈5.6 | 5.3 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 10.3rata-rata 5T ≈4.3 | ≈4.3 | 3.2 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | EQ | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 13.9% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | EQ | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$2.9M | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
26.5%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 13, 2026 | $-0.04 | $-0.06 | 28.7% |
| 31 Maret 2026 | Mei 13, 2026 | $-0.06 | $-0.04 | -34.5% |
| 31 Des. 2025 | $-0.04 | $-0.06 | 35.3% | |
| 30 Sep. 2025 | $-0.06 | $-0.15 | 59.8% | |
| 30 Juni 2025 | $-0.16 | $-0.19 | 16.1% | |
| 31 Maret 2025 | $-0.24 | $-0.35 | 30.5% | |
| 31 Des. 2024 | $-0.16 | $-0.32 | 49.9% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | · | $41M | $36M | $16M | |
| R&D Expense | · | · | $37M | $38M | |
| SG&A Expense | $11M | $12M | $14M | $17M | |
| Operating Expenses | $24M | $49M | $51M | $78M | |
| Operating Income | $-24M | $-8M | $-15M | $-62M | |
| Interest Income | $833.0K | $1M | $2M | $420.0K | |
| Other Non-op | · | · | $-76.0K | $281.0K | |
| Pretax Income | $-22M | $-8M | $-13M | $-62M | |
| Income Tax | $0 | $361.0K | $580.0K | $0 | |
| Net Income | $-22M | $-8M | $-13M | $-62M | |
| EPS (Basic) | $-0.39 | $-0.23 | $-0.38 | $-1.85 | |
| EPS (Diluted) | $-0.39 | $-0.23 | $-0.38 | $-1.85 | |
| Shares (Basic) | 57,304,181 | 35,357,641 | 34,726,384 | 33,727,945 | |
| Shares (Diluted) | 57,304,181 | 35,357,641 | 34,726,384 | 33,727,945 | |
| EBITDA | $-24M | $-8M | $-15M | $-62M |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $18M | $23M | $59M | |
| Receivables | · | $0 | $4M | $3M | |
| Prepaid Expense | $761.0K | $2M | $5M | $3M | |
| Other Current Assets | $214.0K | $429.0K | $235.0K | $8.0K | |
| Current Assets | $31M | $25M | $49M | $77M | |
| PP&E (Net) | $164.0K | $262.0K | $315.0K | $391.0K | |
| Accum. Depreciation | $562.0K | $499.0K | $364.0K | $249.0K | |
| Other Non-current Assets | $27.0K | · | $70.0K | $104.0K | |
| Total Assets | $32M | $26M | $51M | $78M | |
| Accounts Payable | $755.0K | $3M | $5M | $4M | |
| Accrued Liabilities | $2M | $3M | $7M | $7M | |
| Short-term Debt | · | · | · | $6M | |
| Current Liabilities | $3M | $6M | $28M | $32M | |
| Capital Leases | $356.0K | $187.0K | $384.0K | $824.0K | |
| Total Liabilities | $3M | $7M | $28M | $46M | |
| Long-term Debt | · | · | · | $9M | |
| Total Debt | · | · | · | $15M | |
| Common Stock | $5.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-216M | $-194M | $-186M | $-172M | |
| AOCI | $363.0K | $781.0K | $140.0K | $76.0K | |
| Stockholders' Equity | $29M | $19M | $23M | $32M | |
| Liabilities + Equity | $32M | $26M | $51M | $78M | |
| Shares Outstanding | 61,464,368 | 35,557,563 | 35,254,752 | 34,414,149 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| D&A | · | · | · | $118.0K | |
| Stock-based Comp | $2M | $4M | $4M | $5M | |
| Deferred Tax | · | · | · | $0 | |
| Operating Cash Flow | $-23M | $-19M | $-22M | $-9M | |
| CapEx | $48.0K | $85.0K | $50.0K | $279.0K | |
| Investing Cash Flow | $4M | $14M | $-5M | $19M | |
| Stock Repurchased | · | · | $260.0K | · | |
| Net Stock Activity | · | · | $-260.0K | · | |
| Financing Cash Flow | $30M | $164.0K | $-9M | $-1M | |
| Net Change in Cash | $12M | $-5M | $-36M | $9M | |
| Taxes Paid | $352.0K | · | · | · | |
| Free Cash Flow | $-23M | $-19M | $-22M | $-9M |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | · | -20.1% | -40.2% | -393.9% | |
| Net Margin | · | -19.6% | -37.0% | -396.1% | |
| Pretax Margin | · | -18.8% | -35.4% | -396.1% | |
| EBITDA Margin | · | -20.1% | -40.2% | -393.9% | |
| ROA | -77.9% | -21.2% | -20.7% | -76.2% | |
| ROE | -133.1% | -38.2% | -57.1% | -207.7% | |
| ROIC | -82.7% | -45.4% | -67.3% | -133.2% |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 10.6 | 3.9 | 1.8 | 2.4 | |
| Quick Ratio | 10.3 | 2.8 | 1.0 | 1.9 | |
| Debt / Equity | · | · | · | 0.5 | |
| LT Debt / Equity | · | · | · | 0.1 |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 0.6 | 0.2 | |
| Receivables Turnover | · | 22.0 | 11.0 | 11.1 |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.47 | $0.54 | $0.64 | $0.93 | |
| Revenue / Share | · | $1.16 | $1.04 | $0.47 | |
| Cash Flow / Share | $-0.40 | $-0.54 | $-0.63 | $-0.26 | |
| Cash / Share | $0.49 | $0.51 | $0.66 | $1.72 | |
| EPS (TTM) | $-0.39 | $-0.23 | $-0.38 | $-1.85 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | · | 13.9% | 129.0% | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $46M | $41M | $36M | $16M | |
| Net Income TTM | $-22M | $-8M | $-13M | $-62M | |
| Market Cap | $95M | $27M | $25M | $36M | |
| Enterprise Value | · | · | · | $-8M | |
| P/E | -4.0 | -3.3 | -1.9 | -0.6 | |
| P/S | 2.1 | 0.6 | 0.7 | 2.3 | |
| P/B | 3.3 | 1.4 | 1.1 | 1.1 | |
| P / Tangible Book | 3.3 | 1.4 | 1.1 | 1.1 | |
| P / Cash Flow | -4.2 | -1.4 | -1.2 | -4.2 | |
| P / FCF | -4.2 | -1.4 | -1.2 | -4.0 | |
| EV / EBITDA | · | · | · | 0.1 | |
| EV / FCF | · | · | · | 0.9 | |
| EV / Revenue | · | · | · | -0.5 | |
| Earnings Yield | -25.2% | -30.7% | -52.8% | -174.5% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $4M | $12M | $14M | $11M | $9M | $9M | $9M | $9M | |
| SG&A Expense | $2M | $3M | $2M | $3M | $2M | $3M | $2M | $3M | $3M | $4M | $3M | $4M | $3M | $4M | |
| Operating Expenses | $5M | $6M | $4M | $5M | $6M | $9M | $9M | $13M | $14M | $13M | $12M | $12M | $13M | $13M | |
| Operating Income | $-5M | $-6M | $-4M | $-5M | $-6M | $-9M | $-5M | $-679.0K | $-100.0K | $-3M | $-3M | $-4M | $-4M | $-4M | |
| Interest Income | $509.0K | $309.0K | $303.0K | $235.0K | $122.0K | $173.0K | $240.0K | $331.0K | $371.0K | $439.0K | $517.0K | $551.0K | $627.0K | $639.0K | |
| Other Non-op | · | · | · | · | · | · | · | · | · | $-382.0K | · | $-142.0K | $-112.0K | $-179.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | $-3M | $-2M | $-3M | $-3M | $-4M | |
| Income Tax | · | · | $0 | $0 | $0 | $0 | $361.0K | $0 | $0 | $0 | $16.0K | $496.0K | $8.0K | $60.0K | |
| Net Income | $-5M | $-5M | $-4M | $-4M | $-6M | $-9M | $-6M | $-7.0K | $468.0K | $-3M | $-2M | $-4M | $-3M | $-4M | |
| EPS (Basic) | $-0.04 | $-0.06 | $0.07 | $-0.06 | $-0.16 | $-0.24 | $-0.16 | $0.00 | $0.01 | $-0.08 | $-0.06 | $-0.11 | $-0.10 | $-0.11 | |
| EPS (Diluted) | $-0.04 | $-0.06 | $0.07 | $-0.06 | $-0.16 | $-0.24 | $-0.16 | $0.00 | $0.01 | $-0.08 | $-0.06 | $-0.11 | $-0.10 | $-0.11 | |
| Shares (Basic) | 111,805,635 | 96,279,216 | · | 65,322,753 | 35,719,317 | 35,586,861 | · | 35,424,388 | 35,292,035 | 35,254,752 | · | 34,878,700 | 34,449,769 | 34,414,149 | |
| Shares (Diluted) | 111,805,635 | 96,279,216 | · | 65,322,753 | 35,719,317 | 35,586,861 | · | 35,424,388 | 36,589,774 | 35,254,752 | · | 34,878,700 | 34,449,769 | 34,414,149 | |
| EBITDA | $-5M | $-6M | · | $-5M | $-6M | $-9M | · | $-679.0K | $-100.0K | $-3M | · | $-4M | $-4M | $-4M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $57M | $61M | $30M | $33M | $11M | $15M | $18M | $15M | $11M | $12M | $23M | $34M | $26M | $25M | |
| Receivables | · | · | · | · | · | · | · | $5M | $6M | $5M | $4M | $4M | $4M | $3M | |
| Prepaid Expense | $812.0K | $953.0K | $761.0K | $459.0K | $457.0K | $2M | $2M | $3M | $3M | $5M | $5M | $4M | $5M | $5M | |
| Other Current Assets | · | · | $214.0K | $110.0K | $37.0K | $36.0K | $429.0K | $381.0K | $317.0K | $275.0K | $235.0K | · | · | · | |
| Current Assets | $58M | $62M | $31M | $34M | $12M | $16M | $25M | $34M | $42M | $42M | $49M | $54M | $57M | $70M | |
| PP&E (Net) | $188.0K | $214.0K | $164.0K | $174.0K | $201.0K | $233.0K | $262.0K | $293.0K | $329.0K | $361.0K | $315.0K | $313.0K | $329.0K | $360.0K | |
| Accum. Depreciation | · | · | $562.0K | · | · | · | $499.0K | · | · | · | $364.0K | · | · | · | |
| Other Non-current Assets | $27.0K | $27.0K | $27.0K | · | · | · | · | $45.0K | $53.0K | $62.0K | $70.0K | $79.0K | $87.0K | $96.0K | |
| Total Assets | $59M | $63M | $32M | $35M | $12M | $17M | $26M | $34M | $43M | $44M | $51M | $55M | $59M | $72M | |
| Accounts Payable | $850.0K | $1M | $755.0K | $1M | $5M | $3M | $3M | $4M | $4M | $3M | $5M | $4M | $3M | $6M | |
| Accrued Liabilities | $1M | $2M | $2M | $2M | $2M | $3M | $3M | $5M | $7M | $6M | $7M | $8M | $8M | $5M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $6M | |
| Current Liabilities | $2M | $3M | $3M | $3M | $7M | $6M | $6M | $11M | $20M | $22M | $28M | $28M | $25M | $32M | |
| Capital Leases | $172.0K | $251.0K | $356.0K | $473.0K | $109.0K | $149.0K | $187.0K | $223.0K | $259.0K | $295.0K | $384.0K | $498.0K | $609.0K | $719.0K | |
| Total Liabilities | $3M | $4M | $3M | $4M | $7M | $6M | $7M | $11M | $20M | $23M | $28M | $31M | $32M | $43M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $8M | |
| Total Debt | · | · | · | · | · | · | · | · | · | · | · | · | · | $13M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | |
| Retained Earnings | $-226M | $-222M | $-216M | $-212M | $-208M | $-202M | $-194M | $-188M | $-188M | $-188M | $-186M | $-183M | $-180M | $-176M | |
| AOCI | $381.0K | $370.0K | $363.0K | $270.0K | $385.0K | $731.0K | $781.0K | $-3.0K | $251.0K | $423.0K | $140.0K | $458.0K | $340.0K | $305.0K | |
| Stockholders' Equity | $56M | $59M | $29M | $31M | $5M | $11M | $19M | $23M | $22M | $21M | $23M | $24M | $27M | $29M | |
| Liabilities + Equity | $59M | $63M | $32M | $35M | $12M | $17M | $26M | $34M | $43M | $44M | $51M | $55M | $59M | $72M | |
| Shares Outstanding | 63,408,082 | 63,226,556 | 61,464,368 | 60,676,837 | 35,719,317 | 35,719,317 | 35,557,563 | 35,424,388 | 35,424,388 | 35,254,752 | 35,254,752 | 35,119,248 | 34,568,500 | 34,414,149 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $31.0K | $31.0K | $31.0K | |
| Stock-based Comp | $1M | $930.0K | $737.0K | $401.0K | $563.0K | $621.0K | $821.0K | $1M | $952.0K | $972.0K | $1M | $979.0K | $934.0K | $1M | |
| Operating Cash Flow | $-4M | $-4M | $-3M | $-8M | $-3M | $-8M | $-3M | $-8M | $730.0K | $-9M | $-6M | $-2M | $-6M | $-8M | |
| CapEx | $71.0K | $3.0K | $44.0K | $0 | $0 | $4.0K | $4.0K | $0 | $62.0K | $19.0K | $35.0K | · | · | · | |
| Investing Cash Flow | $-71.0K | $-3.0K | $-32.0K | $0 | $0 | $4M | $6M | $12M | $-1M | $-3M | $-6M | $11M | $15M | $-25M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $42.0K | $35M | $283.0K | $30M | $-16.0K | $91.0K | $73.0K | $0 | · | · | $79.0K | $-260.0K | $-8M | $-1M | |
| Net Change in Cash | $-4M | $31M | $-3M | $22M | $-3M | $-4M | $3M | $4M | $-511.0K | $-12M | $-11M | $9M | $1M | $-35M | |
| Free Cash Flow | · | $-4M | · | · | · | $-8M | · | · | · | $-9M | · | · | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | -5.6% | -0.72% | -26.1% | · | -40.8% | -39.4% | -46.3% | |
| Net Margin | · | · | · | · | · | · | · | -0.06% | 3.4% | -25.6% | · | -41.8% | -36.6% | -44.4% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | -25.6% | · | -36.2% | -36.5% | -43.7% | |
| EBITDA Margin | · | · | · | · | · | · | · | -5.6% | -0.72% | -26.1% | · | -40.8% | -39.4% | -46.3% | |
| ROA | -13.2% | -13.3% | · | -12.3% | -20.8% | -28.7% | · | -0.02% | 0.92% | -4.7% | · | -7.1% | -5.5% | -5.4% | |
| ROE | -15.4% | -15.2% | · | -15.6% | -41.8% | -54.6% | · | -0.03% | 1.9% | -10.9% | · | -14.2% | -9.9% | -9.6% | |
| ROIC | · | · | · | · | · | · | · | · | · | -13.2% | · | -17.3% | -13.3% | -9.8% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 23.4 | 18.6 | · | 10.9 | 1.7 | 2.7 | · | 3.0 | 2.1 | 1.9 | · | 1.9 | 2.3 | 2.2 | |
| Quick Ratio | 23.1 | 18.3 | · | 10.7 | 1.6 | 2.4 | · | 1.9 | 0.8 | 0.7 | · | 1.4 | 1.2 | 0.9 | |
| Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.5 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | · | 0.1 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.1 | |
| Receivables Turnover | · | · | · | · | · | · | · | 2.8 | 2.9 | 2.5 | · | 4.7 | 4.9 | 5.2 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.88 | $0.94 | · | $0.51 | $0.14 | $0.30 | · | $0.65 | $0.63 | $0.60 | · | $0.69 | $0.78 | $0.85 | |
| Revenue / Share | · | · | · | · | · | · | · | $0.34 | $0.38 | $0.30 | · | $0.25 | $0.26 | $0.26 | |
| Cash Flow / Share | · | $-0.04 | · | · | · | $-0.23 | · | · | · | $-0.25 | · | · | · | $-0.23 | |
| Cash / Share | $0.90 | $0.97 | · | $0.55 | $0.32 | $0.41 | · | $0.44 | $0.31 | $0.33 | · | $0.98 | $0.74 | $0.71 | |
| EPS (TTM) | $-0.09 | $-0.21 | · | $-0.62 | $-0.56 | $-0.39 | · | $-0.13 | $-0.24 | $-0.35 | · | $-0.19 | $-0.48 | $-0.79 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $41M | $41M | · | $41M | $41M | $41M | · | $46M | $43M | $38M | · | · | · | · | |
| Net Income TTM | $-18M | $-19M | · | $-24M | $-20M | $-14M | · | $-5M | $-8M | $-12M | · | $-8M | $-18M | $-29M | |
| Market Cap | $203M | $126M | · | $87M | $11M | $14M | · | $29M | $24M | $81M | · | $26M | $26M | $25M | |
| Enterprise Value | · | · | · | · | · | · | · | · | · | · | · | · | · | $14M | |
| P/E | -35.6 | -9.5 | · | -2.3 | -0.6 | -1.0 | · | -6.4 | -2.9 | -6.6 | · | -3.9 | -1.6 | -0.9 | |
| P/S | 4.9 | 3.1 | · | 2.1 | 0.3 | 0.3 | · | 0.6 | 0.6 | 2.1 | · | · | · | · | |
| P/B | 3.6 | 2.1 | · | 2.8 | 2.3 | 1.3 | · | 1.3 | 1.1 | 3.9 | · | 1.1 | 1.0 | 0.9 | |
| P / Tangible Book | 3.6 | 2.1 | · | 2.8 | 2.3 | 1.3 | · | 1.3 | 1.1 | 3.9 | · | 1.1 | 1.0 | 0.9 | |
| P / Cash Flow | · | -29.4 | · | · | · | -1.7 | · | · | · | -9.3 | · | · | · | -3.1 | |
| Earnings Yield | -2.8% | -10.5% | · | -43.4% | -175.0% | -100.0% | · | -15.7% | -34.8% | -15.2% | · | -25.7% | -64.0% | -108.2% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | · | $41M | $36M | $16M | · |
| Margin Operasi % | · | -20.1% | -40.2% | -393.9% | · |
| Laba Bersih | $-22M | $-8M | $-13M | $-62M | $-39M |
| EPS Dilusian | $-0.39 | $-0.23 | $-0.38 | $-1.85 | $-1.36 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | · | · | · | 0.5 | 0.2 |
| Rasio Lancar | 10.6 | 3.9 | 1.8 | 2.4 | 9.4 |
| Rasio Cepat | 10.3 | 2.8 | 1.0 | 1.9 | 5.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-23M | $-19M | $-22M | $-9M | $-32M |
Pemilik institusional (13F) 71 pengaju · $132.0M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
71
Nilai yang dipegang
$132.0M
Posisi baru
20
Posisi yang keluar
8
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 20 (0 vs Kuartal sebelumnya) | 8 (+5 vs Kuartal sebelumnya) | 18 (+8 vs Kuartal sebelumnya) | 16 (+4 vs Kuartal sebelumnya) | -5.3M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Decheng Capital LLC | $14.231.386 | 4.447.308 | 10,78% | Saham |
| Affinity Asset Advisors, LLC | $13.120.000 | 4.100.000 | 9,94% | Saham |
| JANUS HENDERSON GROUP PLC | $12.956.669 | 6.494.571 | 9,82% | Saham |
| ADAR1 Capital Management, LLC | $12.027.421 | 3.758.569 | 9,11% | Saham |
| Aberdeen Group plc | $11.621.309 | 3.631.659 | 8,80% | Saham |
| Woodline Partners LP | $11.202.883 | 3.500.901 | 8,49% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $9.908.275 | 3.096.336 | 7,51% | Saham |
| STEMPOINT CAPITAL LP | $6.453.142 | 2.016.607 | 4,89% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.832.998 | 1.822.812 | 4,42% | Saham |
| Eversept Partners, LP | $4.866.637 | 1.520.824 | 3,69% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.448.810 | 1.390.253 | 3,37% | Saham |
| VANGUARD GROUP INC | $2.976.656 | 1.920.423 | 2,26% | Saham |
| TAKEDA PHARMACEUTICAL CO LTD | $2.609.717 | 1.824.977 | 1,98% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $2.040.374 | 637.617 | 1,55% | Saham |
| Exome Asset Management LLC | $1.769.459 | 552.956 | 1,34% | Saham |
| DG Capital Management, LLC | $1.482.867 | 463.396 | 1,12% | Saham |
| DIADEMA PARTNERS LP | $1.280.902 | 400.282 | 0,97% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $1.220.357 | 381.175 | 0,92% | Saham |
| Balyasny Asset Management L.P. | $1.102.109 | 344.409 | 0,83% | Saham |
| TUDOR INVESTMENT CORP ET AL | $1.024.320 | 320.100 | 0,78% | Saham |
| Ikarian Capital, LLC | $971.376 | 303.555 | 0,74% | Saham |
| BlackRock, Inc. | $913.308 | 285.409 | 0,69% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $909.856 | 284.330 | 0,69% | Saham |
| TWO SIGMA INVESTMENTS, LP | $661.930 | 206.853 | 0,50% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $610.592 | 190.810 | 0,46% | Saham |
| STATE STREET CORP | $556.992 | 174.060 | 0,42% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $478.080 | 149.400 | 0,36% | Opsi jual |
| CANTOR FITZGERALD, L. P. | $348.998 | 109.062 | 0,26% | Saham |
| Persistent Asset Partners Ltd | $326.432 | 102.010 | 0,25% | Saham |
| CITADEL ADVISORS LLC | $318.918 | 99.662 | 0,24% | Saham |
| JANE STREET GROUP, LLC | $304.684 | 95.214 | 0,23% | Saham |
| Soleus Capital Management, L.P. | $288.000 | 90.000 | 0,22% | Saham |
| RAYMOND JAMES FINANCIAL INC | $240.832 | 75.260 | 0,18% | Saham |
| NORTHERN TRUST CORP | $228.989 | 71.559 | 0,17% | Saham |
| Cota Capital Management, LLC | $177.230 | 562.278 | 0,13% | Saham |
| AlphaCore Capital LLC | $167.504 | 52.345 | 0,13% | Saham |
| JANE STREET GROUP, LLC | $149.440 | 46.700 | 0,11% | Opsi jual |
| ExodusPoint Capital Management, LP | $141.405 | 44.189 | 0,11% | Saham |
| JANE STREET GROUP, LLC | $141.120 | 44.100 | 0,11% | Opsi beli |
| MILLENNIUM MANAGEMENT LLC | $137.082 | 42.838 | 0,10% | Saham |
| XTX Topco Ltd | $125.642 | 39.263 | 0,10% | Saham |
| Invesco Ltd. | $116.131 | 36.291 | 0,09% | Saham |
| BARCLAYS PLC | $112.000 | 35.000 | 0,08% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $111.040 | 34.700 | 0,08% | Opsi beli |
| Jefferies Financial Group Inc. | $109.120 | 34.100 | 0,08% | Saham |
| High Net Worth Advisory Group LLC | $107.200 | 33.500 | 0,08% | Saham |
| CITIGROUP INC | $104.624 | 32.695 | 0,08% | Saham |
| MORGAN STANLEY | $95.639 | 29.887 | 0,07% | Saham |
| Quadrature Capital Ltd | $91.696 | 28.655 | 0,07% | Saham |
| AMERICAN CENTURY COMPANIES INC | $82.864 | 25.895 | 0,06% | Saham |
Aktivis & pemilik 5%+ 1 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Decheng Capital Global Life Sciences Fund IV, L.P., Decheng Capital Management IV (Cayman), LLC, Decheng Capital Global Healthcare Fund (Master), LP, Decheng Capital Global Healthcare GP, LLC, Xiangmin Cui | 16 Feb. 2021 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 17 orang dalam · 9 pejabat · 9 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Bruce D. Steel | Chief Executive Officer | 7 Jan. 2026 A | 48.495 | 0 | 0 | $0 |
| Jason A Keyes | Chief Financial Officer | 14 Feb. 2025 D | 37.720 | 0 | 0 | $0 |
| Stephen Connelly | President and CSO | 5 Juni 2026 S | 762.025 | 0 | 2 | $-723.066 |
| Christine Zedelmayer | Sr. Vice President and COO | 5 Juni 2026 M | 62.586 | 0 | 16 | $-1.834.153 |
| Penny Tom | Principal Accounting Officer | 28 Mei 2026 M | 0 | 0 | 2 | $-200.178 |
| Daniel Bradbury | CHAIRMAN | 28 Mei 2026 A | 2.969.596 | 0 | 0 | $0 |
| Joel Rothman | Chief Development Officer | 2 Jan. 2024 A | 58.150 | 0 | 0 | $0 |
| Dolca Thomas | Chief Medical Officer | 11 Jan. 2021 A | · | 0 | 0 | $0 |
| Krishna R Polu | Chief Medical Officer | 22 April 2020 A | · | 0 | 0 | $0 |
| Charles Douglas Mcdermott | Direktur | 28 Mei 2026 A | · | 0 | 0 | $0 |
| Barbara Troupin | Direktur | 28 Mei 2026 A | · | 0 | 0 | $0 |
| Mark Pruzanski | Direktur | 28 Mei 2026 A | · | 0 | 0 | $0 |
| Martha J Demski | Direktur | 28 Mei 2026 A | · | 0 | 0 | $0 |
| Peter Colabuono | Direktur | 21 Mei 2025 A | · | 0 | 0 | $0 |
| Bala S Manian | Direktur | 21 Mei 2025 A | · | 0 | 0 | $0 |
| Yu (Katherine) Xu | Direktur | 22 Mei 2024 A | · | 0 | 0 | $0 |
| Biocon SA | Pemilik 10% | 16 Okt. 2018 A | 2.316.134 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 5 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,35% | 52.523 SH | 2 Okt. 2026 | Harian |
| IWC · iShares Trust | 0,03% | 153.076 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 7.665 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 373.367 SH | 19 Agu 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.401.958 SH | 19 Agu 2026 | Harian |
EQ Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 18 analis
BELI
Target median
$7.00
+396,5%
8 44,4%
Beli Kuat
9 50,0%
Beli
1 5,6%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
9 analis · 2026-09-28Target rata-rata $8.56 +506,8%
← Di bawah semua target
Harga saat ini $1.41
Rendah$4.00
Rata-rata$8.56
Tinggi$20.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| EQ | $95M | -4.0 | 13.9% | · | -133.1% | · |
| CTOR | $170M | -6.0 | · | · | -61.5% | · |
| BMEA | $90M | -1.1 | -67.1% | -3326.0% | -216.6% | · |
| CNXU | · | · | · | · | · | · |
| ATRA | $132M | 7.0 | -6.3% | 27.1% | -88.9% | · |
| RLYB | $4M | -0.4 | 34.9% | -1046.4% | -17.3% | · |
| CRDF | $192M | -4.1 | -13.2% | -7732.0% | -88.2% | · |
| MNOV | $64M | -5.5 | · | -2928.8% | -27.1% | · |
| ICCC | · | -51.2 | 4.3% | · | · | · |
| ACRV | $76M | -1.2 | · | · | -61.0% | · |
| SERA | · | -4.4 | 5.2% | -39417.3% | -39.0% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 13, 2026